Better lung cancer detection technology is needed

U of MN to present findings at the American Society of Clinical Oncology 2003 Annual Meeting

MINNEAPOLIS / ST. PAUL (June 2, 2003) -- Lung cancer detection technology is not as accurate or reliable as doctors would like it to be. In a study conducted at the University of Minnesota, doctors found that 40 percent of patients undergoing treatment for presumably curable lung cancer were actually in more advanced stages of the disease. "This study shows how poor the technology for lung cancer detection is," says Robert Kratzke, M.D., University of Minnesota Department of Medicine.

Developing more accurate detection technology for lung cancer was the goal of another study conducted by Kratzke. Preliminary data on immunohistochemical detection, a test that uses antibodies to detect which stage of lung cancer a patient is in, is promising. The rate of lung cancer detection in the lymph nodes doubled when using this measure. Kratzke will present the findings on both of these studies on Tuesday, June 3 at 10 a.m. at the American Society of Clinical Oncology 2003 Annual Meeting in Chicago.

WHAT: The University of Minnesota will present research findings on lung cancer detection technology at the American Society of Clinical Oncology (ASCO) 2003 Annual Meeting

WHO: Robert Kratzke, M.D., University of Minnesota Department of Medicine

WHEN: Tuesday, June 3, 10 a.m.-noon

WHERE: McCormick Place Convention Center, 2301 S. Lake Shore Dr., Chicago, Il

###

[ | E-mail |

Share ]

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.